These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists. Zahradníková A, Minarovic I, Zahradník I. J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903 [Abstract] [Full Text] [Related]
5. Effects of Bay K 8644 on L-type calcium current from newborn rat cardiomyocytes in primary culture. Gomez JP, Fares N, Potreau D. J Mol Cell Cardiol; 1996 Oct; 28(10):2217-29. PubMed ID: 8930816 [Abstract] [Full Text] [Related]
8. PD 122860: a novel dihydropyridine with sodium channel stimulating and calcium channel blocking properties. Haleen SJ, Steffen RP, Sircar I, Major TC, Taylor MD, Pugsley TA, Weishaar RE. J Pharmacol Exp Ther; 1989 Jul; 250(1):22-30. PubMed ID: 2473188 [Abstract] [Full Text] [Related]
9. Two subtypes of dihydropyridine-sensitive calcium channels in rat ventricular muscle. Saxon M, Gainullin R. Eur J Pharmacol; 1990 Mar 13; 178(1):37-45. PubMed ID: 1691983 [Abstract] [Full Text] [Related]
12. Allosteric interactions at L-type calcium channels between FPL 64176 and the enantiomers of the dihydropyridine Bay K 8644. Usowicz MM, Gigg M, Jones LM, Cheung CW, Hartley SA. J Pharmacol Exp Ther; 1995 Nov 13; 275(2):638-45. PubMed ID: 7473149 [Abstract] [Full Text] [Related]
18. Voltage-dependence of Ca2+ agonist effect of YC-170 on cardiac L-type Ca2+ channels. Takeda Y, Tohse N, Nakaya H, Kanno M. Br J Pharmacol; 1995 Oct 21; 116(3):2134-40. PubMed ID: 8640356 [Abstract] [Full Text] [Related]